Significance of HLA Nondependent Risk Factors of Chronic Transplant Nephropathy for the Development of Endothelial Dysfunction After Kidney Transplantation

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1599-1603

  Horcicka, V ^a   Zadrazil, J ^a   Karasek, D ^a   Al JAbry, S ^a   Krejci, K ^a   Strebl, P ^a   Halenka, M ^a   Elfmark, M ^a  

^a Third Department of Internal Medicine   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ENDOTHELIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HEMODIALYSIS; HLA SYSTEM; HUMAN; HUMAN TISSUE; HYPERLIPOPROTEINEMIA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BIOPSY; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CHOLESTEROL; CREATININE; DILATATION, PATHOLOGIC; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HLA ANTIGENS; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RENAL DIALYSIS; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TRIGLYCERIDES; TUNICA MEDIA;

EID: 67249150173     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.10.100     Document Type: Article

References (26)

1. Hostetter T.H. Chronic transplant rejection. Kidney Int 46 (1994) 266
2. Foley R., Roberts T., Fan Q., et al. Comparative analysis of cardiovascular event rates in dialysis, CKD, transplant, and general populations. USRDS, Minneapolis Medical Research Foundation, University of Minnesota Twin Cities (2006)
3. Joosten S.A., Sijpkens Y.W., van Kooten C., et al. Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int 68 (2005) 1
4. Mark P.B., Murphy K., Mohammed A.S., et al. Endothelial dysfunction in renal transplant recipients. Transplant Proc 37 (2005) 3805
5. Oflaz H., Turkmen A., Turgut F., et al. Changes in endothelial function before and after renal transplantation. Transpl Int 19 (2006) 333
6. Oflaz H., Pusuroglu H., Genchallac H., et al. Endothelial function is more impaired in hemodialysis patients than renal transplant recipients. Clin Transplant 17 (2003) 528
7. Asberg A., Berg K.j., and Hartmann A. Each administration of cyclosporin A enhances skin microvascular reactivity in renal transplant recipients. Microvasc Res 60 (2000) 81
8. Tullius S.G., and Tilney N.L. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 59 (1995) 313
9. Kaasjager K.A., Koomans H.A., and Rabelink T.J. Effectiveness of enalapril versus nifedipine to antagonize blood pressure and the renal response to endothelin in humans. Hypertension 25 (1995) 620
10. Celermajer D.S. Endothelial dysfunction: does it matter?. Is it reversible?. J Am Coll Cardiol 30 (1997) 325
11. Marques G.G., Gonneaga P.E., Royo F.J.L., et al. Evolution of the renal function is a better predictor of long term survival than serum creatinine. Transplant Proc 37 (2005) 3701
12. Yilmaz M.I., Saglam M., Caglar K., et al. Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. Transplantation 80 (2005) 1660
13. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005) 2981
14. Woywodt A., Schroeder M., Gwinner W., et al. Elevated numbers of circulating endothelial cells in renal transplant recipients. Transplantation 76 (2003) 1
15. Hunting C.B., Noort W.A., and Zwaginga J.J. Circulating endothelial (progenitor) cells reflect the state of the endothelium: vascular injury, repair and neovascularization. Vox Sang 88 (2005) 1
16. De Groot K., Bahlmann F.H., Sowa J., et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int 66 (2004) 641
17. Halloran P.F. Non immunologic tissue injury and stress in chronic allograft dysfunction. Graft 1 (1998) 23
18. Hayflick L., and Moorhead P.S. The serial cultivation of human diploid cell strains. Exp Cell Res 25 (1961) 585
19. Mercanoglu F., Turkmen A., Kocaman O., et al. Endothelial dysfunction in renal transplant patients is closely related to serum cyclosporine levels. Transplant Proc 36 (2004) 1357
20. Mercanoglu F., Oflaz H., Turkmen A., et al. Does the endothelial function change in renal transplant patients with longer duration of exposure and with higher cumulative doses of cyclosporine?. Transplant Proc 36 (2004) 1361
21. Ovuworie C.A., Fox E.R., Chow C.M., et al. Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. Transplantation 72 (2001) 1385
22. Karasek D., Vaverkova H., Halenka M., et al. Soluble cell adhesion molecules s-VCAM-1 and s-ICAM-1 in subjects with familial combined hyperlipidemia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149 (2005) 101
23. Kosch M., Barenbrock M., Suwelack B., et al. Effect of a 3-year therapy with the 3-hydroxy-3-methylglutaryl coenzyme a reductase-inhibitor fluvastatin on endothelial function and distensibility of large arteries in hypercholesterolemic renal transplant recipient. Am J Kidney Dis 41 (2003) 1088
24. Kapessidou Y., Habran C., Buonocore S., et al. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells. Transplantation 81 (2006) 582
25. Moens L., Goovaerts I., Claeys M.J., et al. Flow mediated vasodilation: a diagnostic instrument, or an experimental tool?. Chest 127 (2005) 2254
26. Meier-Kriesche H.U., Cibrik D.M., Ojo A.O., et al. Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Geriatr Soc 50 (2002) 14